Invesco Ltd. - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 166 filers reported holding WUXI PHARMATECH CAYMAN INC in Q4 2014. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$16,549,000
-23.0%
383,000
-24.7%
0.01%
-12.5%
Q2 2015$21,502,000
+0.1%
508,804
-8.1%
0.01%0.0%
Q1 2015$21,471,000
-63.5%
553,648
-68.3%
0.01%
-65.2%
Q4 2014$58,885,000
-8.3%
1,748,872
-4.6%
0.02%
-11.5%
Q3 2014$64,191,000
+8.8%
1,832,999
+2.1%
0.03%
+13.0%
Q2 2014$59,020,000
-14.1%
1,796,130
-3.6%
0.02%
-17.9%
Q1 2014$68,705,000
-10.6%
1,863,931
-6.9%
0.03%
-9.7%
Q4 2013$76,875,000
+40.4%
2,002,990
+0.2%
0.03%
+29.2%
Q3 2013$54,745,000
+33.1%
1,998,010
+2.0%
0.02%
+26.3%
Q2 2013$41,127,0001,958,4710.02%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q4 2014
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 261,361$8,588,0006.86%
Black Creek Investment Management Inc. 1,644,485$54,038,0005.68%
Consonance Capital Management LP 1,143,315$37,569,0005.59%
Sloane Robinson LLP 120,000$3,943,0002.47%
THOMAS WHITE INTERNATIONAL LTD 470,769$15,469,0002.16%
Grandeur Peak Global Advisors, LLC 295,035$9,695,0002.09%
Mirae Asset Global Investments Co., Ltd. 2,370,406$77,891,0001.73%
Granite Point Capital Management, L.P. 70,000$2,300,0001.58%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 89,810$2,951,0001.38%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$86,315,0001.16%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders